Hybrid molecules of protoflavones and spirooxindole derivatives with selective cytotoxicity against triple-negative breast cancer cells
The combination of compounds with complementary bioactivities into hybrid molecules is an emerging concept in drug discovery. In this study, we aimed to synthesize new hybrid compounds based on p53-MDM2/X protein-protein interaction spiropyrazoline oxindole-based inhibitors and ataxia telangiectasia...
Elmentve itt :
Szerzők: |
Girst Gábor Lopes Elizabeth A. Goncalves Lidia M. Espadinha Margarida Kúsz Norbert Wang Hui-Chun Santos Maria M. M. Hunyadi Attila |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2023
|
Sorozat: | RSC MEDICINAL CHEMISTRY
14 No. 9 |
Tárgyszavak: | |
doi: | 10.1039/d3md00251a |
mtmt: | 34261677 |
Online Access: | http://publicatio.bibl.u-szeged.hu/29306 |
Hasonló tételek
-
Hybrid molecules of tryptophan derivatives and protoflavones to tackle colon cancer [abstract] /
Szerző: Ferreira Ricardo J. F., et al.
Megjelent: (2023) -
Thymoquinone-protoflavone hybrid molecules as potential antitumor agents
Szerző: Ahmed Sara Hassan Hassan, et al.
Megjelent: (2024) -
Studies on bioactive 6-gingerol derivatives and thymoquinone-protoflavone hybrid molecules
Szerző: Ahmed Sara Hassan Hassan
Megjelent: (2024) -
Thymoquinone-protoflavone hybrids studies into anticancer potentials : [abstract] /
Szerző: Ahmed Sara Hassan Hassan, et al.
Megjelent: (2023) -
Less Cytotoxic Protoflavones as Antiviral Agents Protoapigenone 1′-O-isopropyl ether Shows Improved Selectivity Against the Epstein–Barr Virus Lytic Cycle /
Szerző: Vágvölgyi Máté, et al.
Megjelent: (2019)